$aqst
Aquestive Therapeutics ($AQST) faces mixed sentiment as anticipation for Anaphylm's FDA approval clashes with concerns over a potential Complete Response Letter (CRL) and regulatory delays. Recent posts highlight both optimistic trading opportunities and worries about price drops.
About $aqst
Aquestive Therapeutics is a pharmaceutical company focused on developing and commercializing differentiated therapeutics, notably its treatment for anaphylaxis.
Insights
- $aqst mentions hit [---] which is 175% higher than it's daily average.
- $aqst creators hit [---] which is 131% higher than it's daily average.
Engagements: [-----] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [------]
[--] Month: [-------] -37%
[--] Months: [---------] +59%
[--] Year: [---------] +17%
1-Year High: [-------] on 2025-08-11
1-Year Low: [---] on 2025-04-12
Engagements by network (24h): YouTube: [--] Reddit: [--] X: [-----] TikTok: [--]
Mentions: [---] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [--]
1-Year High: [---] on 2025-12-22
1-Year Low: [--] on 2025-05-04
Mentions by network (24h): YouTube: [--] Reddit: [--] X: [---] TikTok: [--]
Creators: [---] (24h)
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning $aqst in the last [--] hours which is up 64% from [--] in the previous [--] hours
Daily Average: [--]
1-Year High: [---] on 2025-06-29
1-Year Low: [--] on 2025-04-20
The most influential creators that mention $aqst in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Stock_Analysis3 | [--] | [---] | [--] | [---] |
| @Rakufl47519 | [--] | [--] | [--] | [---] |
| @yss4318 | [--] | [-----] | [--] | [---] |
| @JaksonMika78723 | [--] | [--] | [--] | [---] |
| @Stock_Marketr14 | [--] | [---] | [--] | [---] |
| @Toby_Garvan | [--] | [--] | [--] | [---] |
| @AscendingBio | [--] | [---] | [--] | [---] |
| @Crypto_News35 | [--] | [--] | [--] | [---] |
| @BiopharmIQ | [--] | [------] | [--] | [---] |
| @Trade_market120 | [--] | [--] | [--] | [---] |
Sentiment: 52%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 52%
Daily Average: 78%
[--] Month: 35% -27%
[--] Months: 35% -40%
[--] Year: 35% -65%
1-Year High: 100% on 2025-02-18
1-Year Low: 6% on 2025-12-14
Most Supportive Themes:
- FDA Approval Anticipation: (40%) Posts express optimism and anticipation for the FDA approval of Anaphylm, highlighting its potential to be superior to existing treatments like EpiPen and nasal sprays.
- Market Analysis and Trading Opportunities: (30%) Several posts focus on identifying trading opportunities, including high implied volatility options and unusual put option volume, suggesting active market interest and speculation.
- Community and Information Sharing: (20%) Users are sharing information, market reports, and inviting others to join trading communities, indicating a desire for collective learning and strategy development.
Most Critical Themes:
- Potential CRL and Price Drop Concerns: (70%) A significant number of posts discuss the possibility of a Complete Response Letter (CRL) from the FDA, with some predicting a substantial price drop if approval is delayed or denied.
- Regulatory Uncertainty and FDA Delays: (30%) The FDA's process, including potential delays and the impact of government shutdowns, is a recurring concern, adding a layer of uncertainty to the stock's outlook.
Top $aqst Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"$AQST $SPRY @BIOTECHSCANNER https://x.com/i/grok/share/1010aeb74cba4c6888a0df2465a4ea17 https://x.com/i/grok/share/1010aeb74cba4c6888a0df2465a4ea17"
X Link @MikeDebreda 2026-02-14T13:29Z [---] followers, [----] engagements
"Big gains under way $BORR $TDW $PUMP $RES $LBRT $SLB $HAL $BKR $FTI $NOV $XOM $OXY $APA $DVN $FANG $MRO $HES $EOG $PXD $CLR $MTDR $SM $CDEV $TALO $WTI $AMPX $TIRX $GXAI $FUSE $AQST $OPRA $NSSC $SGMT $ENLT $AMPG $GITS $MTEK $LASR $CRMD $POM $OFAL $DWTX $PVLA $TTI $ACAD INSIDERS ARE LOADING $PROP WHY ISNT WALL STREET YET While most investors chase headlines the smart money inside Prairie Operating Co. has been quietly building massive positions. Key insiders control a significant chunk of the float Leadership and major holders own https://t.co/Y81oDJoJEm INSIDERS ARE LOADING $PROP WHY ISNT WALL"
X Link @BuyTheUgly 2026-02-13T20:12Z [--] followers, [---] engagements
"$AQST watch out for this one. If they get FDA approved later this year. Could be a [--] dollar stock. nice little sleeper"
X Link @persianoptions 2026-02-13T19:14Z [--] followers, [---] engagements
"🧬 Biotech Weekly News Largest single-day stock moves during the week ending 02/06/26 📈 $AQST 39% FDA Issues Complete Response Letter $CATX 34% Pricing of $175 Million Offering $ROIV 22% Mosliciguat & Brepocitinib Trial Updates $RNAZ 16% IND Amendment for Phase 2a Trial $PRLD 13% FDA Clearance for PRT12396 📉 $ANEB -39% Intention to Voluntarily Delist $SGMO -32% Pricing of $25 Million Offering $ADIL -26% Advancing Clinical Trial Endpoints $PHAR -17% Complete Response Letter for Joenja $SXTP -12% Expands Access to ARAKODA See image below. *** Decoding AQSTs clean CRL and the FDAs endgame for"
X Link @BiopharmIQ 2026-02-07T10:58Z 28.9K followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing